Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
+2.61%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$72.4B
AUM Growth
+$3.34B
(+4.8%)
Cap. Flow
+$3.29B
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
3,872
New
175
Increased
1,612
Reduced
1,555
Closed
162
Top Buys
| 1 |
NVIDIA
NVDA
|
+$393M |
| 2 |
Microsoft
MSFT
|
+$248M |
| 3 |
Amazon
AMZN
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$173M |
| 5 |
Meta Platforms (Facebook)
META
|
+$170M |
Top Sells
| 1 |
Realty Income
O
|
+$86.9M |
| 2 |
Canadian National Railway
CNI
|
+$72M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$58.5M |
| 4 |
Coca-Cola
KO
|
+$58.4M |
| 5 |
Accenture
ACN
|
+$49.7M |
Sector Composition
| 1 | Technology | 26.64% |
| 2 | Financials | 13.44% |
| 3 | Consumer Discretionary | 11.14% |
| 4 | Healthcare | 9.81% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Nelnet
NNI
$4.49B
| $7.28K | ﹤0.01% |
68
+17
| +33% | +$1.82K |
|
3102
Amphastar Pharmaceuticals
AMPH
$1.34B
| $7.28K | ﹤0.01% |
196
-2,818
| -93% | -$105K |
|
3103
ARKO Corp
ARKO
$582M
| $7.28K | ﹤0.01% |
+1,104
| New | +$7.28K |
|
3104
Schwab US REIT ETF
SCHH
$8.43B
| $7.22K | ﹤0.01% |
343
+311
| +972% | +$6.55K |
|
|
ARI
3105
Apollo Commercial Real Estate
ARI
$1.54B
| $7.13K | ﹤0.01% |
823
-126
| -13% | -$1.09K |
|
3106
Buckle
BKE
$3.1B
| $7.06K | ﹤0.01% |
139
+69
| +99% | +$3.51K |
|
3107
Miller Industries
MLR
$465M
| $7.06K | ﹤0.01% |
108
-6
| -5% | -$392 |
|
3108
VanEck Gold Miners ETF
GDX
$20.8B
| $7.05K | ﹤0.01% |
208
+97
| +87% | +$3.29K |
|
3109
Foghorn Therapeutics
FHTX
$304M
| $6.97K | ﹤0.01% |
1,477
| – | – |
|
3110
FRP Holdings
FRPH
$483M
| $6.95K | ﹤0.01% |
227
+185
| +440% | +$5.67K |
|
|
RVNC
3111
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.93K | ﹤0.01% |
2,278
+2,080
| +1,051% | +$6.32K |
|
3112
OmniAb
OABI
$230M
| $6.88K | ﹤0.01% |
1,942
-1,974
| -50% | -$6.99K |
|
3113
Porch Group
PRCH
$1.87B
| $6.87K | ﹤0.01% |
1,396
+546
| +64% | +$2.69K |
|
3114
TTEC Holdings
TTEC
$180M
| $6.87K | ﹤0.01% |
1,376
| – | – |
|
3115
Aclaris Therapeutics
ACRS
$225M
| $6.86K | ﹤0.01% |
2,765
| – | – |
|
3116
Valhi
VHI
$471M
| $6.83K | ﹤0.01% |
292
| – | – |
|
3117
Metagenomi
MGX
$71.3M
| $6.83K | ﹤0.01% |
+1,892
| New | +$6.83K |
|
|
RWT
3118
Redwood Trust
RWT
$812M
| $6.79K | ﹤0.01% |
1,040
+87
| +9% | +$568 |
|
3119
Perspective Therapeutics
CATX
$250M
| $6.7K | ﹤0.01% |
+2,101
| New | +$6.7K |
|
3120
InnovAge Holding
INNV
$566M
| $6.66K | ﹤0.01% |
1,694
-1,945
| -53% | -$7.64K |
|
3121
iShares MSCI Emerging Markets ETF
EEM
$19.8B
| $6.43K | ﹤0.01% |
154
+3
| +2% | +$125 |
|
3122
Compass Minerals
CMP
$771M
| $6.4K | ﹤0.01% |
569
+344
| +153% | +$3.87K |
|
3123
Clover Health Investments
CLOV
$1.59B
| $6.39K | ﹤0.01% |
+2,028
| New | +$6.39K |
|
3124
Tango Therapeutics
TNGX
$713M
| $6.39K | ﹤0.01% |
2,067
+1,998
| +2,896% | +$6.17K |
|
3125
Q32 Bio
QTTB
$22.2M
| $6.39K | ﹤0.01% |
1,856
+1,782
| +2,408% | +$6.13K |
|